Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paniz Zarand

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cardiovascular Drugs and Therapy|December 10, 2024
Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation TherapyDorsa Alijanzadeh, Shahrzad Moghim, Paniz Zarand, et al.
Scientific Reports|March 4, 2024
Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitionsShayesteh Khalili, Seyed Amir Ahmad Safavi-Naini, Paniz Zarand, et al.
Cancers|February 10, 2024
Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain TumorsPaniz Sabeghi, Paniz Zarand, Sina Zargham, et al.
Health Science Reports|April 9, 2025
Proliferative Markers in Breast Cancer and Chemotherapy Implications: A Comprehensive ReviewAryan Salahi-Niri, Paniz Zarand, Fatemeh Shojaeian, et al.
Health Science Reports|March 7, 2025
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic ReviewAryan Salahi-Niri, Paniz Zarand, Negar Mansouri, et al.
Cancer Research Communications|June 5, 2026
p97 Inhibition Synergistically Enhances Hypomethylating Therapy Through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T Nawrocki, Ning Wang, Claudia M Espitia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cardiovascular Drugs and Therapy|December 10, 2024
Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation TherapyDorsa Alijanzadeh, Shahrzad Moghim, Paniz Zarand, et al.
Scientific Reports|March 4, 2024
Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitionsShayesteh Khalili, Seyed Amir Ahmad Safavi-Naini, Paniz Zarand, et al.
Cancers|February 10, 2024
Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain TumorsPaniz Sabeghi, Paniz Zarand, Sina Zargham, et al.
Health Science Reports|April 9, 2025
Proliferative Markers in Breast Cancer and Chemotherapy Implications: A Comprehensive ReviewAryan Salahi-Niri, Paniz Zarand, Fatemeh Shojaeian, et al.
Health Science Reports|March 7, 2025
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic ReviewAryan Salahi-Niri, Paniz Zarand, Negar Mansouri, et al.
Cancer Research Communications|June 5, 2026
p97 Inhibition Synergistically Enhances Hypomethylating Therapy Through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T Nawrocki, Ning Wang, Claudia M Espitia, et al.
Pageof 1